One-Third of European Patients with Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment
Plain language video presentation:
Plain language summary EuroSpA publication 2.2, interview with Lykke Ørnbjerg
Plain language summary text:
“One-third of patients with axial spondyloarthritis experience a period without pain when treated with TNFi”
This is a plain language summary of the scientific publication from EuroSpA: “One-Third of European Patients with Axial Spondyloarthritis
Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment” by Ørnbjerg, Rugbjerg et. al.
You can read the original article published in The Journal of Rheumatology in 2023 here: https://www.jrheum.org/content/early/2023/01/10/jrheum.220459.long
